4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019
- PMID: 30559230
- DOI: 10.2337/dc19-S004
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019
Abstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2018 by the American Diabetes Association.
Similar articles
-
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2020.Diabetes Care. 2020 Jan;43(Suppl 1):S37-S47. doi: 10.2337/dc20-S004. Diabetes Care. 2020. PMID: 31862747 Review.
-
16. Diabetes Advocacy: Standards of Medical Care in Diabetes-2019.Diabetes Care. 2019 Jan;42(Suppl 1):S182-S183. doi: 10.2337/dc19-S016. Diabetes Care. 2019. PMID: 30559242 Review.
-
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019.Diabetes Care. 2019 Jan;42(Suppl 1):S173-S181. doi: 10.2337/dc19-S015. Diabetes Care. 2019. PMID: 30559241 Review.
-
5. Lifestyle Management: Standards of Medical Care in Diabetes-2019.Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60. doi: 10.2337/dc19-S005. Diabetes Care. 2019. PMID: 30559231 Review.
-
7. Diabetes Technology: Standards of Medical Care in Diabetes-2019.Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80. doi: 10.2337/dc19-S007. Diabetes Care. 2019. PMID: 30559233 Review.
Cited by
-
Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes.Endocr Pract. 2024 Jul;30(7):663-669. doi: 10.1016/j.eprac.2024.04.018. Epub 2024 May 1. Endocr Pract. 2024. PMID: 38697305
-
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know.Diabetes Spectr. 2024 Winter;37(1):29-38. doi: 10.2337/dsi23-0014. Epub 2024 Feb 15. Diabetes Spectr. 2024. PMID: 38385100 Free PMC article.
-
Electronically Delivered Nudges to Increase Influenza Vaccination Uptake in Older Adults With Diabetes: A Secondary Analysis of the NUDGE-FLU Trial.JAMA Netw Open. 2023 Dec 1;6(12):e2347630. doi: 10.1001/jamanetworkopen.2023.47630. JAMA Netw Open. 2023. PMID: 38117499 Free PMC article. Clinical Trial.
-
Interactions between Multiple Organs and Nutritional Metabolism in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.Nutrients. 2023 Nov 24;15(23):4910. doi: 10.3390/nu15234910. Nutrients. 2023. PMID: 38068768 Free PMC article.
-
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care.Gut Liver. 2023 Nov 15;17(6):843-852. doi: 10.5009/gnl220545. Epub 2023 Aug 10. Gut Liver. 2023. PMID: 37560797 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials

